Table 2 Proportion of the HCV risk practices at baseline and at M12 and impact of time on HCV risk practices: univariate mixed models
Baseline (MO) | M12 | OR [95% CI] | p | |
|---|---|---|---|---|
n (%) | n (%) | M12 vs. M0 | ||
Sharing injection paraphernalia | 1 (0.6%) | 1 (0.7%) | 1.22 [0.08-19.59] | 0.89 |
Needle sharing | 3 (1.7%) | 1 (0.7%) | 0.40 [0.04-3.89] | 0.43 |
Straw-sharing | 9 (5.1%) | 5 (3.5%) | 0.64 [0.19-2.19] | 0.48 |
At least 1 HCV risk practice associated with drug use | 11 (6.3%) | 6 (4.1) | 0.63 [0.21-1.90] | 0.42 |
At least 1 HCV risk practice associated with other practices | 26 (16%) | 18 (12%) | 0.65 [0.30-1.45] | 0.29 |
At least 1 HCV risk practice | 34 (19%) | 22 (15%) | 0.68 [0.33-1.41] | 0.30 |